#$%^&*AU2017251698A120171109.pdf#####ABSTRACT Compounds represented by the following formula (I); 0 0 S 0 x F R R2 H 2N NH wherein each symbol is as defined in the specification, are useful as hyperglycemic inhibitors having a serine protease 5 inhibitory action and as prophylactic or therapeutic drugs for diabetes.